Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients Up to Age Seventy-Five With Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.12.374
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prospective Trial of Pre-Transplant 5-Azacitidine on Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndrome and CMML

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Outcomes of Allogeneic Stem Cell Transplant in Patients With Chronic Myelomonocytic Leukemia (CMML) - A Single Institution Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Prognostic Impact of Variant Allelic Frequency of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Patients With Acute Erythroleukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Age Does Not Adversely Influence Outcomes Among Patients Older Than 60 Years Who Undergo Allogeneic Hematopoietic Stem Cell Transplant for AML and Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2017English

No Association Between Donor Telomere Length and Outcomes After Allogeneic Unrelated Hematopoietic Cell Transplant in Patients With Acute Leukemia

Bone Marrow Transplantation
TransplantationHematology
2017English

Imatinib Use Either Pre- Or Post-Allogeneic Hematopoietic Cell Transplantation (Allo-Hct) Does Not Increase Cardiac Toxicity in Chronic Myelogenous Leukemia Patients

Bone Marrow Transplantation
TransplantationHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy